STEVEN SCHINKAL: Open Payments
NPI 1376063214 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$305 in 17 payments from 11 companies in 2025. Trend: 2023 $135 · 2024 $290 · 2025 $305
Food & beverage: $305
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 2 | $60 |
| Novo Nordisk Inc | 2 | $40 |
| SANOFI-AVENTIS U.S. LLC | 2 | $37 |
| BETA BIONICS, INC. | 3 | $32 |
| Lilly USA, LLC | 2 | $31 |
| ABBVIE INC. | 1 | $21 |
| Radius Health, Inc. | 1 | $20 |
| Amgen Inc. | 1 | $18 |
| KYOWA KIRIN, INC. | 1 | $17 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
Products named: MINIMED 780G, TZIELD, iLet Bionic Pancreas, MOUNJARO, Rybelsus, Tymlos, TEPEZZA, Ozempic.
Industry payments across NY — which companies pay providers there.
